124 related articles for article (PubMed ID: 20415741)
21. The role of NLRP1 and NLRP3 inflammasomes in the etiopathogeneses of pityriasis lichenoides chronica and mycosis fungoides: an immunohistochemical study.
Bostan E; Gokoz O; Atakan N
Arch Dermatol Res; 2023 Mar; 315(2):231-239. PubMed ID: 35776169
[TBL] [Abstract][Full Text] [Related]
22. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
23. Ichthyosiform eruptions in association with primary cutaneous T-cell lymphomas.
Morizane S; Setsu N; Yamamoto T; Hamada T; Nakanishi G; Asagoe K; Iwatsuki K
Br J Dermatol; 2009 Jul; 161(1):115-20. PubMed ID: 19416265
[TBL] [Abstract][Full Text] [Related]
24. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
Mao X; Orchard G; Russell-Jones R; Whittaker S
Br J Dermatol; 2007 Nov; 157(5):914-21. PubMed ID: 17725669
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
26. [Primary cutaneous lymphoma, with the exception of mycosis fungoides].
Joly P; Charlotte F; Leibowitch M; Haioun C; Wechsler J; Dreyfus F; Escande JP; Revuz J; Bagot M
Ann Dermatol Venereol; 1992; 119(6-7):457-62. PubMed ID: 1444106
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
[TBL] [Abstract][Full Text] [Related]
28. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
29. The expression of MUM1 in cutaneous T-cell lymphoproliferative disorders.
Wasco MJ; Fullen D; Su L; Ma L
Hum Pathol; 2008 Apr; 39(4):557-63. PubMed ID: 18234282
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
[TBL] [Abstract][Full Text] [Related]
31. Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge.
Lalevee S; Ortonne N; Hotz C; Schlemmer F; Beldi-Ferchiou A; Delfau-Larue MH; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
Eur J Dermatol; 2018 Dec; 28(6):834-835. PubMed ID: 30325315
[No Abstract] [Full Text] [Related]
32. The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 11-year-old girl.
Niemczyk UM; Zollner TM; Wolter M; Staib G; Kaufmann R
Br J Dermatol; 1997 Dec; 137(6):983-7. PubMed ID: 9470920
[TBL] [Abstract][Full Text] [Related]
33. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
34. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
35. An ultrastructural morphometric and immunohistochemical analysis of cutaneous lymphomas and benign lymphocytic infiltrates of skin. Useful criteria for diagnosis.
Payne CM; Grogan TM; Lynch PJ
Arch Dermatol; 1986 Oct; 122(10):1139-54. PubMed ID: 3490225
[TBL] [Abstract][Full Text] [Related]
36. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
37. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
38. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
39. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
40. Foxp3 expression in cutaneous T-cell lymphocytic infiltrates.
Solomon GJ; Magro CM
J Cutan Pathol; 2008 Nov; 35(11):1032-9. PubMed ID: 18681861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]